Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05205980 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Perturbation Training Reduces Falls in People With Alzheimer's Disease (AD)

Study acronym: STAD
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Eligibility criteria revised
    • Study title expanded, about 2 words
    v10
  2. Primary and study completion dates: Jun 30, 2025 to Oct 30, 2026v9
  3. Primary and study completion dates: Jun 30, 2024 to Jun 30, 2025v8
  4. Primary endpoint revisedv7
  5. Start date: Oct 18, 2022 to Apr 28, 2023v6 Show 7 more changesShow less
    • Primary endpoint revised
    • Enrollment target: 42 to 30
    • Primary and study completion dates: Sep 30, 2024 to Jun 30, 2024
    • Secondary endpoints: details revised at 1 of 2 entries
    • Study description expanded, about 16 words
    • Collaborators: 1 to 2
    • Eligibility criteria shortened, about 5 words
Show 4 earlier versionsHide 4 earlier versions
  1. Start date changed from estimate of Oct 2022 to Oct 18, 2022v5
  2. Trial status: Not Yet Recruiting to Recruiting
    • Start date: Aug 2022 to Oct 2022
    • Study sites: 0 to 1
    v4
  3. Start date: Apr 2022 to Aug 2022v3
  4. Start date: Feb 2022 to Apr 2022v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study will examine the overall capacity of people with Alzheimer's disease learning fall-resistant skills from perturbation training.
Trial Details
NCT Number NCT05205980
Lead Sponsor Georgia State University
Collaborators: National Institutes of Health (NIH), Alzheimer's Association
Conditions
(from sponsor)		 Alzheimer Disease
Related terms Alzheimer Disease
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov